Compare JRVR & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JRVR | INGN |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.7M | 173.2M |
| IPO Year | 2014 | 2013 |
| Metric | JRVR | INGN |
|---|---|---|
| Price | $6.57 | $6.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $6.75 | ★ $11.00 |
| AVG Volume (30 Days) | 236.8K | ★ 283.7K |
| Earning Date | 06-02-2026 | 05-18-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | ★ 125.82 | 43.42 |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $687,614,000.00 | $348,668,000.00 |
| Revenue This Year | $1.50 | $7.92 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | $8.33 | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $3.85 | $5.34 |
| 52 Week High | $7.20 | $9.13 |
| Indicator | JRVR | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 50.91 |
| Support Level | $6.25 | $6.12 |
| Resistance Level | $7.02 | $6.90 |
| Average True Range (ATR) | 0.29 | 0.30 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 38.95 | 39.77 |
James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.